共 50 条
- [21] USES OF TOXICOLOGY DATA FOR MEDICAL DEVICES - THE FDA PERSPECTIVE[J]. JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY, 1988, 7 (04): : 499 - 507WEST, DL
- [22] FDA recognizes: Simulation essential to evaluate medical devices[J]. Adv Mater Processes, 4 (32-33):SIMULIA, Dassault Systèmes, Rising Sun Mills, 166 Valley Rising St., Providence, RI 02909-2499, United States
- [23] Tort law deference to FDA regulation of medical devices[J]. GEORGETOWN LAW JOURNAL, 2000, 88 (07) : 2119 - 2145Green, MDSchultz, WB
- [24] SUBSTANTIALLY UNEQUIVALENT: REFORMING FDA REGULATION OF MEDICAL DEVICES[J]. UNIVERSITY OF ILLINOIS LAW REVIEW, 2014, (04): : 1363 - 1400Lennox, Kyle
- [25] BAYESIAN STATISTICS IN MEDICAL DEVICES: INNOVATION SPARKED BY THE FDA[J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2011, 21 (05) : 871 - 887Campbell, Gregory
- [26] FDA Recognizes Simulation Essential to Evaluate Medical Devices[J]. ADVANCED MATERIALS & PROCESSES, 2013, 171 (04): : 32 - 33Liu, Cheryl
- [27] What does "FDA Approved" mean for medical devices?[J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (01): : 4 - 6Nygaard, Ingrid
- [28] The FDA may not regulate tobacco products as "drugs" or as "medical devices"[J]. DUKE LAW JOURNAL, 1998, 47 (06) : 1071 - 1094Merrill, RA
- [29] Combining FDA labeling and LLDP for securing networked medical devices[J]. Biomedical Instrumentation and Technology, 2016, 50 : 48 - 51Sayle, Robert
- [30] Industry perspective on FDA regulation of medical devices and the practice of medicine[J]. ANNALS OF THORACIC SURGERY, 1996, 61 (01): : 485 - 486Tandy, MK